Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Bone marrow NK cell profile predicts MRD negativity in myeloma patients treated with dara-based therapy; low proportion of CD16+ BM NK cells with decreased cytokine production and degranulation associated with reduced MRD-negativity.”
Authors: Charlotte Korst, Sabrin Tahri, Carolien Duetz, Tom Cupedo, Niels van de Donk et al.
More posts featuring Robert Orlowski.
